This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Speakers Highlight Proton Therapy Treatment For Cancer

HAMPTON, Va., Feb. 4, 2013 /PRNewswire-USNewswire/ -- On Tuesday, Feb. 5, at NASA's Langley Research Center here, medical physicist Cornel Butuceanu will present, "Proton Radiotherapy Systems and Clinical Practice," at 2 p.m. in the Reid Conference Center.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)  

A former postdoctoral fellow at the Thomas Jefferson National Accelerator Facility, Butuceanu joined the Hampton University Proton Therapy Institute (HUPTI) in 2009 and participated in all aspects of bringing the center to clinical readiness. The $225 million treatment and research center expects to see over 2,000 patients per year for prostate, brain, lung, pediatric, head and neck, breast and other cancers.

Butuceanu will be available to answer questions from the media during a news briefing at 1:15 p.m. that day. Media who wish to do so should contact Chris Rink at 757-864-6786, or by e-mail at chris.rink@nasa.gov, by noon on the day of the talk for credentials and entry to the Center.

That same evening at 7:30, Keith Gregory, deputy executive director at HUPTI, will present a related presentation for the general public at the Virginia Air & Space Center in downtown Hampton. This Sigma Series event is free and no reservations are required.

As cancer remains the second leading cause of death in the United States according to the U.S. Department of Health and Human Services, HUPTI is the first proton therapy institute in the Mid-Atlantic region, and the only facility of its kind in Virginia.

Butuceanu's presentation will focus on an introduction to proton therapy; it's medical advantages over current treatments; the evolution of the accelerators and beam delivery systems; cost effectiveness; applications to clinical radiation oncology; and the future outlook for proton therapy.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs